Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 21;6(6):e555. doi: 10.1097/TXD.0000000000001003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 1. — Median serotype-specific antibody levels in lung transplant candidates before vaccination, after vaccination with 13vPCV, before vaccination with 23vPPV (thus 8 wk after 13vPCV), and after vaccination with 23vPPV. Note that the scale of the y-axis is different for all serotypes. Median antibody levels were significantly higher compared with baseline after vaccination with 13vPCV (Wilcoxon signed ranks test; P < 0.01 for all serotypes). 23vPPV, 23-valent pneumococcal polysaccharide vaccine; 13vPCV, 13-valent pneumococcal conjugate vaccine.